TUESDAY, Dec. 22 (HealthDay News) -- Hormonal contraceptives have useful non-contraceptive benefits, including prevention of endometrial and ovarian cancer and treating menstruation-related disorders, according to an American College of Obstetricians and Gynecologists practice bulletin published in the January issue of Obstetrics & Gynecology.

Based on a review of the scientific data on the use of hormonal contraceptives for non-contraceptive uses, the bulletin notes that good and consistent scientific evidence has shown that combined oral contraceptives should not be used to treat ovarian cysts. However, combined oral contraceptives reduce the risk of endometrial and ovarian cancer and can reduce menstrual bleeding, dysmenorrhea, premenstrual dysphoric disorder symptoms, and acne.

The bulletin further notes that more limited or inconsistent scientific evidence suggests that combined oral contraceptives do not increase the risk of developing uterine leiomyomas, and that contraceptives may be useful in treating menorrhagia in women who may wish to become pregnant.

"Although there is little data on the newer forms of hormonal contraception in terms of their off-label benefits, experts suggest that they may be as effective as the more studied ones in treating the same conditions," Robert L. Reid, M.D., from Queen's University in Kingston, Canada, who helped develop the bulletin, commented in a press release.

Abstract
Full Text (subscription or payment may be required)